In the Russian hospital received the first batch of the drug favipiravir (TN Aviewer), stated in a press release GK “Khimrar” and the Russian direct investment Fund (RDIF).
According to the report, the drug received the clinic and authorized pharmaceutical organizations of Moscow, Leningrad, Novgorod, Kirov, Nizhny Novgorod regions, the Republic of Tatarstan and Ekaterinburg. In June, the Russian hospitals must obtain 60 thousand courses of the drug.
29 may drug Aviewer produced by the company “Chemrar” was registered by the Ministry of health of the Russian Federation under the accelerated procedure – a drug recommended for the treatment of coronavirus infection (COVID-19). Favipiravir included in version 7 of the clinical recommendations for the treatment of coronavirus infection, the Ministry of health.
According to the CEO of RDIF, Kirill Dmitriev, the manufacturer of Avifauna received requests for delivery of the drug in more than 10 countries.